Nifty
:
24631.30
Sensex
:
80597.66
11.95 (0.05%)
57.75 (0.07%)
Nifty
Sensex
:
:
24631.30
80597.66
11.95 (0.05%)
57.75 (0.07%)

PCBL Chemical Ltd.

Chemicals

Rating :
51/99

BSE: 506590 | NSE: PCBL

NSE BSE
378.30
14-Aug-2025
  • Open
  • High
  • Low
  • Previous Close
  •  381
  •  382.95
  •  375.25
  •  379.90
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  332503
  •  125970519.65
  •  584.4
  •  331

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 14,277.52
  • 34.77
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 19,268.31
  • 1.45%
  • 3.88

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 51.41%
  • 4.16%
  • 24.41%
  • FII
  • DII
  • Others
  • 5.52%
  • 11.04%
  • 3.46%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.07
  • 25.87
  • 13.33

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.47
  • 20.44
  • 12.41

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 38.84
  • 6.74
  • -0.55

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 13.15
  • 13.17
  • 20.88

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.36
  • 2.50
  • 3.04

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 9.59
  • 9.93
  • 11.73

Earnings Forecasts:

(Updated: 06-06-2025)
Description
2024
2025
2026
2027
Adj EPS
13
11.51
15.05
20.41
P/E Ratio
29.10
32.87
25.14
18.54
Revenue
6420
8404
9278
10487
EBITDA
989
1337
1546
1798
Net Income
491
435
583
781
ROA
5.9
3.8
12.3
13.3
P/B Ratio
4.35
3.86
3.46
3.05
ROE
16.16
12.52
14.69
17.53
FCFF
418
-469
575
767
FCFF Yield
2.04
-2.29
2.81
3.75
Net Debt
4561
5182
4248
3983
BVPS
86.88
97.96
109.47
124.19

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
EBITDA
319.05
358.27
-10.95%
297.66
309.51
-3.83%
317.34
278.94
13.77%
363.51
238.12
52.66%
EBIDTM
15.09%
16.71%
14.26%
16.05%
15.79%
16.84%
16.80%
16.02%
Other Income
5.80
10.88
-46.69%
19.77
23.20
-14.78%
11.09
7.17
54.67%
5.65
2.68
110.82%
Interest
112.35
121.11
-7.23%
103.16
108.19
-4.65%
117.72
32.37
263.67%
118.92
20.97
467.10%
Depreciation
92.35
84.47
9.33%
88.14
75.19
17.22%
86.66
52.65
64.60%
86.41
48.24
79.13%
PBT
120.15
163.57
-26.55%
126.13
149.33
-15.54%
123.53
201.09
-38.57%
163.83
171.59
-4.52%
Tax
26.05
45.65
-42.94%
25.94
38.38
-32.41%
30.42
53.11
-42.72%
40.38
48.76
-17.19%
PAT
94.10
117.92
-20.20%
100.19
110.95
-9.70%
93.11
147.98
-37.08%
123.45
122.83
0.50%
PATM
4.45%
5.50%
4.80%
5.75%
4.63%
8.93%
5.71%
8.26%
EPS
2.49
3.13
-20.45%
2.65
2.95
-10.17%
2.46
3.92
-37.24%
3.27
3.25
0.62%
Net Sales
2,114.05
2,143.56
-1.38%
2,087.49
1,928.78
8.23%
2,010.00
1,656.76
21.32%
2,163.20
1,486.71
45.50%
Expenses
1,795.00
1,785.29
0.54%
1,789.83
1,619.27
10.53%
1,692.66
1,377.82
22.85%
1,799.69
1,248.59
44.14%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
8,374.74
8,404.25
6,419.77
5,774.06
4,446.42
2,659.52
3,243.54
3,528.56
2,557.94
1,926.95
1,894.10
Net Sales Growth
16.06%
30.91%
11.18%
29.86%
67.19%
-18.01%
-8.08%
37.95%
32.75%
1.73%
 
Cost Of Goods Sold
5,815.02
5,759.79
4,456.29
4,352.45
3,133.80
1,608.93
2,189.51
2,296.56
1,670.27
1,236.54
1,344.55
Gross Profit
2,559.72
2,644.46
1,963.48
1,421.61
1,312.62
1,050.59
1,054.03
1,232.00
887.67
690.41
549.55
GP Margin
30.56%
31.47%
30.58%
24.62%
29.52%
39.50%
32.50%
34.92%
34.70%
35.83%
29.01%
Total Expenditure
7,077.18
7,121.02
5,431.10
5,059.20
3,825.04
2,153.13
2,784.40
2,914.44
2,185.12
1,687.84
1,750.31
Power & Fuel Cost
-
89.33
42.89
26.14
25.52
28.11
22.96
28.44
26.53
21.65
22.02
% Of Sales
-
1.06%
0.67%
0.45%
0.57%
1.06%
0.71%
0.81%
1.04%
1.12%
1.16%
Employee Cost
-
412.82
250.41
190.46
158.90
132.35
134.55
111.12
97.36
81.97
72.79
% Of Sales
-
4.91%
3.90%
3.30%
3.57%
4.98%
4.15%
3.15%
3.81%
4.25%
3.84%
Manufacturing Exp.
-
279.60
214.37
161.55
161.11
127.79
132.51
161.76
137.16
105.23
89.74
% Of Sales
-
3.33%
3.34%
2.80%
3.62%
4.81%
4.09%
4.58%
5.36%
5.46%
4.74%
General & Admin Exp.
-
96.31
74.91
52.51
44.38
31.65
39.04
66.56
55.25
39.74
20.77
% Of Sales
-
1.15%
1.17%
0.91%
1.00%
1.19%
1.20%
1.89%
2.16%
2.06%
1.10%
Selling & Distn. Exp.
-
203.42
170.77
122.95
155.61
124.69
123.71
114.88
94.85
71.03
68.66
% Of Sales
-
2.42%
2.66%
2.13%
3.50%
4.69%
3.81%
3.26%
3.71%
3.69%
3.62%
Miscellaneous Exp.
-
279.75
221.46
153.14
145.72
99.61
142.12
135.10
103.69
131.67
68.66
% Of Sales
-
3.33%
3.45%
2.65%
3.28%
3.75%
4.38%
3.83%
4.05%
6.83%
6.96%
EBITDA
1,297.56
1,283.23
988.67
714.86
621.38
506.39
459.14
614.12
372.82
239.11
143.79
EBITDA Margin
15.49%
15.27%
15.40%
12.38%
13.97%
19.04%
14.16%
17.40%
14.58%
12.41%
7.59%
Other Income
42.31
100.94
85.70
56.97
60.17
29.65
33.92
21.98
32.77
37.65
37.88
Interest
452.15
460.91
180.78
53.41
29.09
33.88
45.90
36.78
41.44
51.45
72.10
Depreciation
353.56
345.68
217.26
136.74
120.89
110.12
92.36
66.38
60.52
60.62
62.15
PBT
533.64
577.58
676.33
581.68
531.57
392.04
354.80
532.94
303.63
164.69
47.40
Tax
122.79
142.39
185.22
139.49
105.23
78.05
67.30
150.27
74.03
96.00
31.49
Tax Rate
23.01%
24.68%
27.39%
23.98%
19.80%
19.91%
18.97%
28.20%
24.38%
58.29%
66.43%
PAT
410.85
434.60
490.94
441.80
426.02
313.63
286.55
383.70
228.84
69.29
16.33
PAT before Minority Interest
410.63
434.67
491.11
442.19
426.34
313.99
287.50
382.67
229.60
68.69
15.92
Minority Interest
-0.22
-0.07
-0.17
-0.39
-0.32
-0.36
-0.95
1.03
-0.76
0.60
0.41
PAT Margin
4.91%
5.17%
7.65%
7.65%
9.58%
11.79%
8.83%
10.87%
8.95%
3.60%
0.86%
PAT Growth
-17.78%
-11.48%
11.12%
3.70%
35.84%
9.45%
-25.32%
67.67%
230.26%
324.31%
 
EPS
10.88
11.51
13.01
11.70
11.29
8.31
7.59
10.16
6.06
1.84
0.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
3,697.44
3,246.69
2,830.17
2,613.99
1,935.46
1,699.12
1,649.89
1,377.58
1,130.70
1,044.82
Share Capital
37.75
37.75
37.75
37.75
34.47
34.47
34.47
34.47
34.47
34.47
Total Reserves
3,547.69
3,208.94
2,792.42
2,576.24
1,900.99
1,664.65
1,615.42
1,343.11
1,096.23
1,010.35
Non-Current Liabilities
5,127.86
5,659.96
1,382.68
587.98
684.60
993.51
531.66
392.23
395.50
356.56
Secured Loans
3,546.49
3,776.64
407.31
220.34
304.74
215.01
273.63
164.25
190.16
204.37
Unsecured Loans
100.36
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
1,034.23
841.41
644.84
0.50
0.86
419.32
1.31
0.70
0.66
4.22
Current Liabilities
4,919.37
4,073.26
2,445.76
2,168.44
1,098.46
1,028.09
1,559.80
1,326.97
1,211.50
1,311.86
Trade Payables
1,594.72
1,802.02
956.40
911.12
591.63
418.77
508.29
401.88
416.17
271.25
Other Current Liabilities
1,045.26
812.22
393.06
208.25
165.46
195.70
150.82
80.60
67.05
201.53
Short Term Borrowings
1,158.48
505.60
420.00
374.97
256.92
329.67
452.02
522.64
548.14
705.35
Short Term Provisions
1,120.91
953.42
676.30
674.10
84.45
83.95
448.68
321.84
180.14
133.73
Total Liabilities
13,756.39
12,983.64
6,667.74
5,378.65
3,726.05
3,727.99
3,747.20
3,103.37
2,743.53
2,719.91
Net Block
6,590.33
6,887.76
1,963.16
1,929.61
1,742.42
1,639.92
1,495.83
1,394.71
1,383.10
1,415.89
Gross Block
8,403.08
7,808.05
2,666.41
2,496.28
2,189.96
1,977.53
1,741.98
1,575.04
1,505.83
1,478.01
Accumulated Depreciation
1,812.75
920.29
703.25
566.67
447.54
337.61
246.15
180.32
122.73
62.12
Non Current Assets
9,009.19
8,682.40
4,061.46
2,513.96
2,256.67
2,584.21
1,972.47
1,843.59
1,715.11
1,673.55
Capital Work in Progress
731.68
433.04
1,130.01
175.25
266.76
305.58
175.04
66.84
79.59
79.69
Non Current Investment
516.11
396.17
233.84
257.99
196.27
155.08
261.51
320.23
200.27
130.05
Long Term Loans & Adv.
1,158.29
953.87
726.95
143.76
49.81
481.28
32.91
59.48
21.91
16.47
Other Non Current Assets
8.30
7.08
3.02
2.87
1.41
2.35
7.18
2.31
30.24
31.45
Current Assets
4,747.20
4,301.24
2,606.28
2,864.69
1,469.38
1,143.78
1,774.74
1,259.78
1,028.43
1,046.35
Current Investments
0.00
36.85
0.00
330.00
0.00
0.00
105.11
0.00
95.03
98.08
Inventories
1,268.15
999.31
571.39
603.91
444.84
326.19
460.29
309.90
243.52
244.22
Sundry Debtors
1,793.74
1,710.24
1,110.65
1,105.10
708.50
588.24
652.66
521.97
465.66
438.15
Cash & Bank
389.16
384.80
95.59
159.09
264.38
152.10
115.46
172.57
24.53
51.86
Other Current Assets
1,296.15
53.15
16.64
12.40
51.66
77.25
441.22
255.34
199.70
214.04
Short Term Loans & Adv.
1,256.57
1,116.89
812.01
654.19
42.74
39.15
424.89
239.56
187.78
191.51
Net Current Assets
-172.17
227.98
160.52
696.25
370.92
115.69
214.94
-67.19
-183.08
-265.50
Total Assets
13,756.39
12,983.64
6,667.74
5,378.65
3,726.05
3,727.99
3,747.21
3,103.37
2,743.54
2,719.90

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
760.49
1,105.40
504.09
290.42
385.01
532.05
289.90
292.56
346.44
422.00
PBT
577.06
676.33
581.68
531.57
392.04
354.80
532.94
303.63
164.69
47.40
Adjustment
768.94
352.70
161.30
126.82
121.32
122.75
105.91
165.97
106.11
111.92
Changes in Working Capital
-407.53
291.92
-73.13
-264.40
-62.35
120.88
-220.84
-108.73
109.45
273.86
Cash after chg. in Working capital
938.47
1,320.95
669.85
393.99
451.01
598.43
418.01
360.88
380.25
433.18
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-177.98
-215.55
-165.76
-103.57
-66.00
-66.38
-128.12
-68.32
-33.80
-11.18
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-690.32
-4,214.09
-551.94
-540.70
-202.67
-106.84
-277.52
-34.31
-35.89
-121.46
Net Fixed Assets
-328.75
-195.30
-323.51
-168.41
-147.93
-366.09
-275.14
-62.33
-28.24
-186.45
Net Investments
-317.29
-2,669.47
-222.45
-562.76
-43.55
211.54
-46.39
-28.38
-64.82
-176.31
Others
-44.28
-1,349.32
-5.98
190.47
-11.19
47.71
44.01
56.40
57.17
241.30
Cash from Financing Activity
-63.93
3,380.76
-30.57
216.70
-179.54
-389.36
-70.40
-109.88
-337.09
-261.59
Net Cash Inflow / Outflow
6.24
272.07
-78.42
-33.58
2.80
35.85
-58.03
148.37
-26.53
38.95
Opening Cash & Equivalents
312.29
40.22
118.64
152.22
149.42
113.57
171.60
23.23
49.84
10.75
Closing Cash & Equivalent
318.53
312.29
40.22
118.64
152.22
149.42
113.57
171.60
23.23
49.84

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
94.98
86.00
74.97
69.24
56.15
98.59
95.74
79.93
65.61
60.63
ROA
3.25%
5.00%
7.34%
9.37%
8.42%
7.69%
11.17%
7.85%
2.51%
0.66%
ROE
12.72%
16.16%
16.24%
18.74%
17.28%
17.17%
25.28%
18.31%
6.31%
2.05%
ROCE
12.11%
14.48%
17.96%
19.20%
17.53%
16.84%
25.11%
17.32%
10.93%
6.30%
Fixed Asset Turnover
1.04
1.23
2.24
1.90
1.28
1.74
2.13
1.70
1.43
1.51
Receivable days
76.09
80.19
70.03
74.44
88.98
69.82
60.75
69.02
77.39
82.78
Inventory Days
49.24
44.65
37.15
43.05
52.91
44.25
39.84
38.68
41.77
46.68
Payable days
107.63
112.97
78.31
87.51
114.61
62.53
58.22
71.46
80.24
46.98
Cash Conversion Cycle
17.70
11.88
28.87
29.97
27.28
51.54
42.37
36.24
38.92
82.48
Total Debt/Equity
1.50
1.48
0.33
0.26
0.31
0.36
0.48
0.52
0.67
0.98
Interest Cover
2.25
4.74
11.89
19.27
12.57
8.73
15.49
8.33
4.20
1.66

Annual Reports:

FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016

News Update:


  • PCBL Chemical incorporates wholly owned subsidiary in USA
    29th Jul 2025, 09:17 AM

    The company has subscribed to 1,000 equity shares of PCBL Chemical USA Inc., each having a face value of $1, aggregating to a total consideration of $1,000

    Read More
  • PCBL Chemical’s arm secures US patent for next-gen energy storage technologies
    21st Jul 2025, 11:42 AM

    This breakthrough patent represents a significant milestone in its R&D efforts and strengthens its intellectual property portfolio in the energy storage domain

    Read More
  • PCBL Chemical raises Rs 100 crore through Commercial Paper
    15th Jul 2025, 15:51 PM

    The Commercial Paper has a tenure of 90 days and a coupon rate of 6.05% per annum

    Read More
  • PCBL Chemical’s arm commences commercial production of polymer at Mahad facility
    21st May 2025, 14:51 PM

    The consolidated installed capacity of Aquapharm to produce Polymer now stands at 21.8 KTA per annum

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.